News

Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.
Guardant Health (GH) announced a strategic collaboration with Pfizer (PFE) to support the development and commercialization of Pfizer’s ...
The Conners scale can be used to screen children and adults for ADHD. However, research is mixed on its effectiveness. Regardless, it should not be the only assessment used when diagnosing ADHD.
A spokesperson for NHS Humber Health Partnership said: "Staff who apply for a staff parking permit must agree to the terms and conditions at the time of application. Each car park has signage ...
Dublin City Schools has trained 25 new mental health specialists, all graduates of a two-year master's program at Ohio State University. The program, funded by federal COVID-related grants ...
The Mahoning County Career & Technical Center (MCCTC) has secured grant funding to develop a Health and Wellness Center in partnership with Mercy Health and Cadence Care Network. The new 13,000 ...
LANSING, Mich. (WILX) - The University of Michigan Health-Sparrow Lansing has a new president. Ann Marie Creed, who has extensive experience in healthcare leadership, has been named president of ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $31.00. The company’s shares closed yesterday ...
which states that Sussex Partnership NHS Foundation Trust (SPFT) ‘requires improvement’ – following an inspection in May last year. The news comes amid a change in structure for mental health ...
New York is part of a $335 million multistate settlement with a spin-off company of the pharmaceutical giant Pfizer for its role in the opioid epidemic over the last twenty years. The leaders of ...
Pfizer Inc. ’s longtime chief scientist is joining Blackstone Inc. to advise the private equity giant on its investments into advanced new medicines. Mikael Dolsten, who retired from Pfizer late last ...